Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cetrimide 0.5% cream
1310050D0AAAAAA
|
Cetrimide (Topical) | Cetrimide | Skin | 114 |
|
Bazuka Extra Strength Treatment 26% gel
1307000M0BXADBM
|
Bazuka | Salicylic acid | Skin | 113 |
|
Cuderm moisturising cream
130201000BBLXA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 111 |
|
Lamisil AT 1% spray
131002030BBACAB
|
Lamisil (Topical) | Terbinafine hydrochloride | Skin | 111 |
|
Nerisone 0.1% oily cream
1304000L0BBABAB
|
Nerisone | Diflucortolone valerate | Skin | 110 |
|
Emulsifying ointment 50% / Liquid paraffin 50% ointment
130201000AADMDM
|
Generic compound emollients | Other emollient preparations | Skin | 109 |
|
Occlusal 26% solution
1307000M0BTAABA
|
Occlusal | Salicylic acid | Skin | 108 |
|
Videne 10% antiseptic solution
1311040K0BBAAAT
|
Videne | Iodine compounds | Skin | 108 |
|
Dithranol 0.1% cream
1305020F0AACZCZ
|
Dithranol (Topical) | Dithranol | Skin | 105 |
|
Dalonev ointment
1305020D0BFAAAF
|
Dalonev | Calcipotriol | Skin | 104 |
|
Glutaraldehyde 10% solution
1307000F0AAAAAA
|
Glutaraldehyde | Glutaraldehyde | Skin | 104 |
|
Nutraplus 10% cream
1302010U0BDAAAF
|
Nutraplus | Urea | Skin | 104 |
|
Sterets Unisept 0.05% solution 25ml sachets
1311020L0BJAAAG
|
Unisept | Chlorhexidine gluconate | Skin | 104 |
|
White soft paraffin 15% / Liquid paraffin 6% cream
130201000AADLDL
|
Generic compound emollients | Other emollient preparations | Skin | 103 |
|
HiBi Liquid Hand Rub+ 0.5% solution
1311020L0BFAAAL
|
HiBi | Chlorhexidine gluconate | Skin | 101 |
|
Coal tar soln 5% in Betamethasone valerate 0.025% oint
1304000F0AAECEC
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 97 |
|
Dandrazol Anti-dandruff 2% shampoo
1309000I0BEABAA
|
Dandrazol | Ketoconazole | Skin | 97 |
|
Cetavlex 0.5% cream
1310050D0BCAAAA
|
Cetavlex | Cetrimide | Skin | 92 |
|
Generic Eucerin UreaRepair Plus 10% urea lotion
130201000AADRDR
|
Generic compound emollients | Other emollient preparations | Skin | 91 |
|
Alclometasone 0.05% cream
1304000B0AAAAAA
|
Alclometasone dipropionate | Alclometasone dipropionate | Skin | 90 |
|
Sunsense lip balm SPF 50
130801000BBNUA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 87 |
|
Brulidine 0.15% cream
1310050K0BBAAAA
|
Brulidine | Dibrompropamidine isetionate | Skin | 86 |
|
Salicylic acid 5% ointment in a base
1305020S0AACZCZ
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 86 |
|
MooGoo Sensitive skin balm
131500000BBNDA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 85 |
|
Videne 7.5% surgical scrub solution
1311040K0BBADAK
|
Videne | Iodine compounds | Skin | 82 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.